Dr. Lana JanesAdvisor
Dr. Lana Janes is a biopharmaceutical industry veteran with over 20 years of pharmaceutical development experience that spans the full life cycle of therapeutic product development. She is currently a Venture Partner at adMare BioInnovations where she is focussed on identifying compelling areas of strategic commercial opportunity, and driving the creation and acceleration of new therapeutic companies for Canada’s life science sector. Before joining adMare, Lana served as Senior Vice President, Intellectual Property and Technology Development and Chief Patent Officer at QLT Inc. where she oversaw all aspects of global R&D and IP strategy for the company's commercial, clinical and pre-clinical stage ophthalmic therapeutic programs. She has also served as COO of Retinagenix Therapeutics, a Seattle-based privately held ophthalmology company focused on the development of therapeutics for rare diseases of the retina.